Inventor · Carmel, IN, US

Michael Joseph Sofia

55Patents
26h-index
38Co-inventors
88Inventor score

Filing activity: Apr 18, 1988 → Nov 16, 2023

Most-cited inventions

PatentTitleAreaCited byStatus
US7964580B2 Nucleoside phosphoramidate prodrugs Emerging Cross-Sectional Technologies 156 Active
US8173621B2 Nucleoside cyclicphosphates Chemistry; Metallurgy 106 Active
US8334270B2 Nucleoside phosphoramidate prodrugs Emerging Cross-Sectional Technologies 102 Active
US8580765B2 Nucleoside phosphoramidate prodrugs Emerging Cross-Sectional Technologies 80 Active
US8563530B2 Purine nucleoside phosphoramidate Chemistry; Metallurgy 74 Active
US8618076B2 Nucleoside phosphoramidates Chemistry; Metallurgy 73 Active
US8735372B2 Nucleoside phosphoramidate prodrugs Emerging Cross-Sectional Technologies 72 Active
US8551973B2 Nucleoside analogs Chemistry; Metallurgy 67 Active
US8642756B2 Nucleoside phosphoramidates Emerging Cross-Sectional Technologies 67 Active
US8759510B2 Nucleoside cyclicphosphates Chemistry; Metallurgy 60 Active
US8765710B2 2′,4′-substituted nucleosides as antiviral agents Chemistry; Metallurgy 58 Active
US8716263B2 Synthesis of purine nucleosides Emerging Cross-Sectional Technologies 57 Active
US8841275B2 2′-spiro-nucleosides and derivatives thereof useful for treating hepatitis C virus and dengue virus infections Emerging Cross-Sectional Technologies 52 Active
US8859756B2 Stereoselective synthesis of phosphorus containing actives Chemistry; Metallurgy 52 Active
US8716262B2 Nucleoside phosphoramidates Emerging Cross-Sectional Technologies 49 Active
US8906880B2 Nucleoside phosphoramidate prodrugs Emerging Cross-Sectional Technologies 48 Active
US8629263B2 Nucleoside phosphoramidates Emerging Cross-Sectional Technologies 46 Active
US5324743A Leukotriene B.sub.4 antagonists Chemistry; Metallurgy 45 Expired
US9085573B2 Nucleoside phosphoramidate prodrugs Emerging Cross-Sectional Technologies 38 Active
US5478857A Use of PLA.sub.2 inhibitors as treatment for alzheimer's disease Human Necessities 38 Expired
US8957046B2 Nucleoside phosphoramidate prodrugs Emerging Cross-Sectional Technologies 35 Active
US8735569B2 Nucleoside phosphoramidates Chemistry; Metallurgy 32 Active
US9045520B2 Synthesis of purine nucleosides Emerging Cross-Sectional Technologies 30 Active
US5352690A 1,2,4-trioxygenated benzene derivatives useful as leukotriene antagonists Chemistry; Metallurgy 30 Expired
US8569478B2 Modified 4′-nucleosides as antiviral agents Chemistry; Metallurgy 29 Active

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.